Tryptophan metabolism in vitamin B6-deficient mice by Bender, DA et al.
British Journal of Nutrition
http://journals.cambridge.org/BJN
Additional services for British Journal of Nutrition:
Email alerts: Click here
Subscriptions: Click here
Commercial reprints: Click here
Terms of use : Click here
Tryptophan metabolism in vitamin B6­deﬁcient mice
David A. Bender, Eliud N. M. Njagi and Paul S. Danielian
British Journal of Nutrition / Volume 63 / Issue 01 / January 1990, pp 27 ­ 36
DOI: 10.1079/BJN19900089, Published online: 09 March 2007
Link to this article: http://journals.cambridge.org/abstract_S0007114590000083
How to cite this article:
David A. Bender, Eliud N. M. Njagi and Paul S. Danielian (1990). Tryptophan metabolism in 
vitamin B6­deﬁcient mice. British Journal of Nutrition,63, pp 27­36 doi:10.1079/BJN19900089
Request Permissions : Click here
Downloaded from http://journals.cambridge.org/BJN, IP address: 144.82.107.39 on 16 Aug 2012
British Journal of Nutrition (1990), 63, 21-36 27 
Tryptophan metabolism in vitamin B,-deficient mice 
BY DAVID A. BENDER,  E L I U D  N. M. N J A G I  A N D  P A U L  S. D A N I E L I A N  
Department of Biochemistry, University College and Middlesex School of Medicine, 
University College London, Cower Street, London WClE  6BT 
(Received 22 February 1989-Accepted 1 August 1989) 
- _ _ - _ ~ - - _ _ ~ _ _ _ _ _ ~ ~  
Vitamin B, deficiency was induced in mice by maintenance for 4 weeks on a vitamin B,-free diet. 
Tryptophan metabolism was assessed by determining the urinary excretion of tryptophan metabolites, the 
metabolism of It4Cjtryptophan in vivo and the formation of tryptophan and niacin metabolites by isolated 
hepatocytes. The vitamin B,-deficient animals excreted more xanthurenic acid and 3-hydroxykynurenine, 
and less of the niacin metabolites N'-methyl nicotinamide and methyl-2-pyridone-4-carboxamide, than 
did control animals maintained on the same diet supplemented with 5 mg vitamin B,/kg. After 
intraperitoneal injection of ['4C]tryptophan, vitamin B,-deficient mice showed lower liberation of I4CO, 
from Imethylene-'4Cjtryptophan and IU-L4C)tryptophan than did controls, indicating impairment of 
kynureninase (EC 3 . 7 . 1  .3) activity. There was no difference between the two groups of animals in the 
metabolism of (ring-2-I4C]tryptophan. Hepatocytes isolated from the vitamin B,-deficient animals 
formed more 3-hydroxykynurenine and xanthurenic acid than did cells from control animals, but also 
formed more NADP and free niacin. 
Tryptophan metabolism: Vitamin B, deficiency : Mice 
~. __ _ _  
Vitamin B, deficiency results in abnormal metabolism of tryptophan because the enzyme 
kynureninase (EC 3.7.1 .3) in the oxidative pathway of tryptophan metabolism (see Fig. 
1) is pyridoxal phosphate (vitamin B,)-dependent. In deficiency its activity is severely 
impaired, so that, especially after a loading dose of tryptophan, there is increased 
accumulation of its substrates, kynurenine and 3-hydroxykynurenine, and increased 
formation of xanthurenic and kynurenic acids. This results in increased urinary excretion 
of these compounds (Lepkovsky & Nielson, 1942; Lepkovsky et al. 1943). The ability to 
metabolize a test dose of tryptophan has been used widely as a means of assessing vitamin 
B, nutritional status (Coursin, 1964; Allegri et a]. 1978), although the validity and 
reliability of the tryptophan load test have been challenged (Coon & Nagler, 1969; Bender 
& Wynick, 1981; Bender, 1983h, 1987). 
In vitro investigation of the kinetic variables of the enzymes involved in the oxidative 
pathway of tryptophan metabolism suggests that even under normal conditions the 
activities of kynureninase (Knox, 1953) and kynurenine hydroxylase (EC 1.14.13.9) 
(Bender & McCreanor, 1985) are so low that they are likely to provide (secondary) rate- 
limiting steps in the pathway. Significant amounts of kynurenine, 3-hydroxykynurenine, 
kynurenic acid and xanthurenic acid are excreted by animals fed on a diet providing 
adequate vitamin B,, suggesting that in vivo the activities of kynurenine hydroxylase and 
kynureninase may be inadequate to cope with the metabolic flux through tryptophan 
dioxygenase (EC 1 .13.11. I 1). 
Studies of tryptophan metabolism in isolated hepatocytes do not support the view that 
kynureninase may be a rate-limiting step under normal conditions. Salter e l  al. (1986) 
determined metabolic flux through discrete sectors of the oxidative pathway and calculated 
that the control coefficient (that proportion of the total control of metabolic flux that can 
be attributed to an individual step) for kynureninase was < 0.004. The over-whelming 
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Fig. I .  The metabolism of tryptophan and nicotinamide nucleotides. a, Tryptophan dioxygenase(EC I .13.11. I I): 
b, formylkynurenine formamidase (EC 3 . 5 .  I .9) ; c, kynurenine hydroxylase (EC 1 .14.13.9); d, kynureninase 
( E C  3 . 7 .  1.3); e,  3-hydroxyanthranilic acid oxidase (EC I . 13.11.6); f, kynurenine aminotransferase (EC 
2.6 .1 .7) :  g, picolinate carboxylase (EC4.  I .  1.45); h, quinolinic acid phosphoribosyltransferase (EC 2.4.2.19); 
i, nicotinamide phosphoribosyltransferase (EC 2.4.2.12);  j, NAD glycohydrolase (EC 3.2 .2 .5)  or poly(ADP- 
ribose) transferasc (EC 2.4.2.30);  k, nicotinamide N-methyl transferase (EC 2 .  I .  1 .1 ) ;  1, aldehyde oxidase (EC 
I . 2 , 3 ,  I ) .  *The label from [ring-2-'*C]tryptophan is released as formate, and that from [~pethylene-~'CC]tryptophan 
as alanine(t): both are metabolized onwards to "CO,. 
control of metabolic flux was attributable to tryptophan dioxygenase (control coefficient 
0.75) and the uptake of tryptophan into the cells (control coefficient 0.25). Induction of 
tryptophan dioxygenase by the previous administration of glucocorticoid hormones (the 
conditions under which Knox (1953) suggested that kynureninase would become rate- 
limiting) resulted in an increase in the control coefficient of transport to 0 7 5  and a decrease 
in the control coefficient of tryptophan dioxygenase to 0.25. 
The present study was designed to investigate further the metabolism of tryptophan 
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in vitamin B,-deficient animals ; in hepatocytes from vitamin Be-deficient animals, 
kynureninase does have a significant control coefficient (0.41) (Stanley et af. 1985). 
M E T H O D S  
Male BK albino mice were purchased as weanlings from Banting & Kingman (Hull, 
Humberside) and were assigned randomly to receive either a vitamin B,-free diet or the 
same diet supplemented with 5 mg pyridoxine hydrochloride/kg, as described previously 
(Symes et al. 1984). The animals were maintained in groups of five per cage, and received 
food and water ad lib. 
Once each week the animals were transferred to individual metabolism cages, and urine 
was collected for 24 h. Each urine sample was diluted to 20 ml with distilled water and then 
frozen and stored at  - 20" until required for the determination of tryptophan metabolites, 
as described later. They were allowed free access to food and water during this period. 
After the animals had been receiving the diets for 3-4 weeks, they received 0.1 pCi 
[14C]tryptophan by intraperitoneal injection at 09.00 hours, and were transferred to 
separate sealed glass jars, through which air was passed slowly from a compressor. Exhaled 
air was bubbled through I ml 2-methoxyethylamine in a narrow tube to trap 14C0,. The 
2-methoxyethylamine was changed at  10 min intervals for 2 h and was then mixed with 
3 ml Ecoscint-A water-miscible scintillation fluid (National Diagnostics, Aylesbury, Bucks) 
and radioactivity was determined in a liquid-scintillation spectrometer. Each animal 
received an intraperitoneal injection of [ring-2-14C]tryptophan (CEA, Gif-sur-Yvette, 
France ; specific activity 50 Ci/mol) to assess metabolic flux through tryptophan 
dioxygenase and formylkynurenine formamidase (EC 3.5 .1  .9) on the first day, [methylene- 
14C]tryptophan (Amersham International plc, Amersham, Bucks; specific activity 59 Ci/ 
mol) to assess metabolic flux through kynurenine hydroxylase and kynureninase on the 
next day, and [U-14C]tryptophan (NEN; Du Pont (UK) Ltd, Stevenage, Herts; specific 
activity 556 Ci/mol) to assess overall oxidative metabolism on the third day. (In previous 
studies (Bender, 1983 a), [benzene ring-U-14C]tryptophan was used to give a more precise 
estimate of metabolic flux through picolinate carboxylase (EC 4.1 . 1 .45) and the total 
oxidative branch of the pathway ; this positional isomer of [14C]tryptophan is no longer 
available.) On the day the animals received [ring-2-14C]tryptophan, they received a second 
intraperitoneal injection, of 0.1 pCi [14C]formate (Amersham International plc, Amersham, 
Bucks; specific activity 59 Ci/mol), 2 h after the injection of tryptophan, in order to ensure 
that any changes in the liberation of 14C0, from [ring-2-14C]tryptophan were not due to 
changes in the onward metabolism of the formate released by formylkynurenine 
formamidase. Similarly, after the injection of [methylene-14C]tryptophan the animals 
received an injection of 0.1 pCi [U-14C]alanine (Amersham International plc, Amersham, 
Bucks; specific activity 171 Ci/mol), in order to exclude artifacts due to changes in the 
onward metabolism of the alanine released by kynureninase. In each case the collection of 
"CO, was continued for a further 2 h. 
During the fourth and fifth weeks after weaning, isolated hepatocytes were prepared 
from one animal each day by perfusion of the liver with collagenase (EC 3.4.24.3) from 
the superior vena cava to the hepatic portal vein, as described previously (Bender & 
Olufunwa, 1988); the viability of the cells was assessed by Trypan blue exclusion. After the 
superior vena cava had been cannulated, a sample of blood (0.2-0.5 ml) was drawn from 
the inferior vena cava, which was then ligated. The hepatic portal vein was then cut, and 
perfusion commenced. 
The hepatocytes were incubated for 30 min at  37" in a final volume of 10 ml (5-10 mg 
dry weight of cells/incubation) with 60 pmol tryptophan/l. The formation of kynurenine, 
2-2 
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3-hydroxykynurenine, xanthurenic acid, total nicotinamide nucleotides (NAD and NADP, 
oxidized and reduced forms), total niacin (nicotinic acid plus nicotinamide), N'-methyl 
nicotinamide, and methyI-2-pyridone-4-carboxamide, was determined as described pre- 
viously (Bender & Olufunwa, 1988). 
The blood which was withdrawn from the inferior vena cava before the beginning of the 
perfusion was centrifuged at 2000 g for 15 min. Plasma tryptophan was determined by the 
norharman fluorimetric method (Denckla & Dewey, 1967). The activation of aspartate 
aminotransferase (EC 2.6 .1  . I )  by pyridoxal phosphate was determined in the lysed 
washed erythrocyte pellet as an index of vitamin B, nutritional status, by the modification 
of the [2,3-"H]aspartate method of Schuster rt  al. (1978) described previously (Bender rt ul. 
1982), with and without pre-incubation in 0.25 mmol pyridoxal phosphate/ 1.  The results 
have been expressed as the activation coefficient, the ratio of activity after activation of 
apo-enzyme with pyridoxal phosphate : basal activity of native holoenzyme. 
Urine xanthurenic and kynurenic acids and kynurenine were determined after 
chromatography of 10 ml samples of the diluted urine on small columns of Dowex 50W 
(Hi) ion-exchange resin, as described by Satoh & Price (1958). Xanthurenic and kynurenic 
acids were determined fluorimetrically (Satoh & Price, 1958) and kynurenine col- 
orimetrically after diazotization and coupling to naphthyl ethylenediamine (Joseph & 
Risby, 1975). 3-Hydroxykynurenine was determined fluorimetrically after reaction with p- 
toluene sulphonyl chloride in acetone (Watanabe er ut. 1970), N1-methyl nicotinamide by 
the small-scale modification of the alkali-ketone fluorimetric method of Carpenter & 
Kodicek (1950) that has been described previously (Bender, I980), and methyl-2-pyridone- 
4-carboxamide colorimetrically by hypobromite-catalysed rearrangement to the amine, 
diazotization and coupling to naphthyl ethylenediamine (Holman, 1954), after removal of 
potentially interfering substances with MB-5 1 13 mixed-bed ion-exchange resin (Bender, 
1983 h). 
R E S U L T S  
As shown in Table I ,  the vitamin B,-deficient animals grew more slowly than those fed on 
the control diet, showing a mean gain in weight of 11 % over the 4 weeks of the experiment, 
compared with a gain of 31 YO in the control animals. After 4 weeks on the diet, the 
erythrocyte aspartate aminotransferase activation coefficient was 1.44 (SE 0.103) in the 
deficient animals, and 1.09 (SE 0.066) in the control animals (0.05 > P > 0.01, t test). There 
was no significant difference in the plasma concentration of tryptophan (control 72.7 
(SE 5.27) ,umol/I, vitamin B,-deficient 76.4 (SE 8.54); P > 0.1, f test). 
Table 1 shows the urinary excretion of tryptophan metabolites at weekly intervals 
through the study. 3-Hydroxykynurenine excretion was significantly higher in the deficient 
animals throughout the experiment. Urinary kynurenic acid showed no consistent 
difference between the two groups of animals ; xanthurenic acid excretion was slightly 
higher throughout, significantly so after 3 and 4 weeks on the deficient diet. N1-methyl 
nicotinamide and methyl pyridone carboxamide excretion were consistently lower in the 
deficient animals; the differences were significant in weeks 3 and 4 for methyl pyridone 
carboxamide, and in week 4 for "-methyl nicotinamide. 
Fig. 2 shows the effects of vitamin B, deficiency for 4 weeks on the metabolism of 
[''Cltryptophan, formate and alanine in intact mice. There was no significant effect of diet 
on the liberation of 14C0, from [ring-2-14C]tryptophan or [14C]formate (P > 0.1, analysis 
of variance), although there was a suggestion of an early greater rate of tryptophan 
metabolism in the deficient animals ('"CO., liberation at 10 min: 7.34 (SE 0.724) counts/min 
per lo3 cpm injected in deficient animals, 4.47 (SE 0.364) in controls; P < 0-001, t test). As 
shown in Table 2, there was no significant difference in the total amount of W O ,  recovered 
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Table 2. Total recovery of I4CO, from [14C]tryptophan, ['4Clforniate and [ U-14C]alanine in 
vitamin B,-deJicient and control mice in vivo after intraperitoneal injection 
(Values are means with their standard errors for five animals in each group) 
~ _ _ _ _ _ _ _ _ ~ _ _ _ _  
14C0, (cpm/ lo3 cpm injected) 
Control Vitamin B,-deficient 
Mean SE Mean SE 
_ _ _ _ _ _ _ _  _________ ________ 
[R1ng-2-'~C]tryptophdn 397 309 40 2 3 49 
[14C]formate 365 149 36 6 185  
[Methylene-14C] tryptophan 365  308 27 I *  2 42 
[U-"C]alanine 75 1 5 15 86 6 6 56 
[U-14C]tryptophan 376 258 27 8** 158 
- ~ ~ ~ _ _ _ ~ ~ _ _ _  ~~ _ _ -  _ _ _ - _ _ _ - _ _ _ _ _ _ _ _ _ _ _ - -  
cpm, counts/min 
Values for the control group were significantly different from those for the deficient group ( t  test) * O  1 > 
P > 005, **005 > P >  001 
Table 3. The formation of tryptophan metabolites (nmol formed /30 min per mg dry wt of 
cells) by isolated hepatocytes incubated for 30 min with 60 pmol tryptophunll 
(Values are means with their standard errors for cells Isolated from five animals in each group) 
~ ~ ~ _ _ _ _ _ _ ~ _ _ ~ ~ ~ ~ _ _ _ _  ______ 
Control Vitamin B,-deficient 
- 
Medl1 SE Mean SE 
Kynurenine 2.9 0.38 
3-Hydroxykynurenine 0.82 0.027 
Xanthurenic acid 7.7 0.67 
NADP 0 6 5  0103 
Niacin 15.2 0.96 
N'-methyl nicotinamide 0.07 0.009 
Methyl pyridone carboxamide 1.3 0.34 
2.3 0.16 
1.46** 0134 
9.3* 0.60 
1.22** 0.21 
23.4** 2.17 
007  0.0 15 
1 5  0 1 2  
_ _ _ _ _ _ _ _ _  _ _ _ _ ~  
Values for the deficient group were significantly different from those for the control group ( t  test): * 0 1  > 
P > 0.05: **0.05 > P > 0.01. 
from [ring-2-14C]tryptophan or [14C]formate over 2 h. The deficient animals showed 
significantly reduced liberation of 14C0, from [methylene-14C]tryptophan ( P  = 0.0069, 
analysis of variance), but slightly increased liberation of 14C0, from [14C]alanine. The 
reduced flux through kynureninase suggested by the reduction in 14C0, liberation 
from [methylene-"Cltryptophan was reflected in a reduced liberation of I4CO, from 
[U-"Cltryptophan (P = 0.047, analysis of variance). 
As shown in Table 3 ,  hepatocytes isolated from vitamin B,-deficient animals formed 
more 3-hydroxykynurenine, xanthurenic acid, NADP and niacin than did cells from 
animals fed on the control diet. There was no significant difference in the formation of 
kynurenine, N1-methyl nicotinamide or methyl pyridone carboxamide. 
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D I S C U S S I O N  
Previous studies with rats (Symes et ul. 1984; Bowden et ul. 1986; Bender et ul. 1989) have 
shown that maintenance for 3 4  weeks from weaning on the vitamin B,-free diet used in 
the present study results in a significant degree of vitamin B, depletion, as assessed by the 
liver content of pyridoxal phosphate. In the present study, in mice, the same diet led to the 
development of significant vitamin B, deficiency, as assessed by the erythrocyte aspartate 
aminotransferase activation coefficient. 
The deficient mice showed the expected abnormalities of excretion of tryptophan 
metabolites : an elevation of urinary 3-hydroxykynurenine and xanthurenic acid, even in 
the absence of a loading dose of tryptophan. There was also a reduction in the excretion 
of N'-methyl nicotinamide and methyl pyridone carboxamide, the two end-products of the 
pathway. The metabolic fate of aminocarboxymuconic semialdehyde (see Fig. 1 )  will 
depend on the balance between the (saturable) enzymic reaction of picolinate carboxylase 
(leading to total oxidation) and non-enzymic cyclization to quinolinic acid (the precursor 
of NAD), which has linear kinetics. Hence, the formation of NADP changes considerably 
as the rate of formation of aminocarboxymuconic semialdehyde changes. This in turn 
depends on the rate of metabolic flux through the pathway from tryptophan (Mehler et ul. 
1964; Tkeda et ui. 1965). Reduced activity of kynureninase resulting from vitamin B, 
deficiency would, therefore, be expected to result in the reduced formation of NADP and 
the niacin metabolites W-methyl nicotinamide and methyl pyridone carboxamide shown in 
Table 1.  
The production of "CO, from [14C]tryptophan in intact animals, shown in Fig. 2 and 
Table 2, is also in agreement with expectations. There was no effect of vitamin B, deficiency 
on the production of "CO, from [ring-2-l4C]tryptophan, which reflects the activity of 
tryptophan dioxygenase. There was clear impairment of the activity of kynureninase in vivo 
in vitamin B, deficiency, with a significant reduction in the peak height and total 
production of 'TO,  from [methylene-14C]tryptophan in the deficient animals. This was not 
an artifact of reduced metabolism of the alanine released by kynureninase : indeed there was 
a slight increase in the production of ' T O ,  from [U-14C]alanine in the deficient animals. 
The production of "CO, from [U-14C]tryptophan showed the same effect as did that from 
[methylene-14C]tryptophan, suggesting that the activity of picolinate carboxylase, and 
hence total oxidation of tryptophan via acetate, is not affected by vitamin B, deficiency. 
The results with isolated hepatocytes are at variance with those in intact animals. As 
shown in Table 3, there was indeed increased formation of 3-hydroxykynurenine and 
xanthurenic acid in hepatocytes from vitamin B,-deficient animals, but this was 
accompanied by increased formation of NADP and free niacin, whereas urinary excretion 
of niacin metabolites was reduced in the deficient animals. 
It is difficult to reconcile the results in intact animals, which show the expected increase 
in urinary excretion of kynurenine metabolites and reduced excretion of niacin metabolites 
in vitamin B, deficiency, with those obtained in hepatocytes isolated from the same 
animals, which show increased formation of both kynurenine and niacin metabolites. It is 
possible that vitamin B, deficiency affects either the catabolism of NADP or the 
methylation of nicotinamide to N'-methyl nicotinamide, although there is no evidence that 
the enzymes involved are vitamin B,-dependent. It may be that an artifact is induced during 
the isolation of hepatocytes by perfusion of the liver with collagenase, so that the isolated 
hepatocyte is not a useful model for such studies. Alternatively, it is possible that studies 
of whole-body tryptophan metabolism reflect not only hepatic, but also extra-hepatic, 
metabolism of tryptophan and kynurenine. 
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